Disclosed embodiments concern a composition and/or combination, and a method of administering the same as a feed, or to supplement the feed of, aquatic animals, particularly for aquaculture. Disclosed composition and/or combination embodiments may comprise glucan, silica, mineral clay, mannans, yucca, quillaja, a probiotic, and/or an adhesive agent. The adhesive agent may be selected particularly to facilitate administration to aquatic species. In certain embodiments the adhesive agent comprises an oil, such as soy oil, or a syrup, such as molasses, or combinations thereof. In some embodiments the composition and/or combination may further comprise polyphenol, an antimicrobial, and/or a vaccine. Also disclosed is a method for promoting growth and/or immune function in aquatic animals.

Provided herein are compositions and methods for the inhibition of enteric infection. In particular, compositions comprising bacteria of the class Clostridia are administered to human and/or animal subjects to prevent or decrease susceptibility to enteric infection.

Provided herein are compositions and methods for the inhibition of enteric infection. In particular, compositions comprising bacteria of the class Clostridia are administered to human and/or animal subjects to prevent or decrease susceptibility to enteric infection.

An isolated Bacillus altitudinis strain as deposited with the National Collection of Industrial and Marine Bacteria under the Accession No. NCIMB 43558 on 27/01/2020.

An isolated Bacillus altitudinis strain as deposited with the National Collection of Industrial and Marine Bacteria under the Accession No. NCIMB 43558 on 27/01/2020.

Provided are a Lactobacillus helveticus strain and a composition for preventing or treating inflammatory disease containing the same. The Lactobacillus helveticus strain (Accession No. KCTC 14110BP) according to the present invention alleviates symptoms of inflammatory bowel disease, such as weight loss and bowel length reduction, and it does not have side effects that have been seen with existing drug treatment. Therefore, the Lactobacillus helveticus strain can be effectively used for the treatment and prevention of inflammatory disease, particularly inflammatory bowel disease.

A system, method, and apparatus for ensiling hydroponically grown cellulosic material is disclosed. A grower system for growing plants and crops provides an aerobic environment by controlling a plurality of environmental factors that decrease environmental stresses surrounding the plants or crops. The decrease in environmental stresses increases hydrolytic enzyme activity and releases additional hydrolytic enzymes. The hydrolytic enzymes breakdown a plurality of complex storage molecules of the plant or crop into simple storage molecules. The breakdown of the plurality of complex storage molecules increases the nutrient availability and dry matter of the ensiled cellulosic material as well as the shelf life of the ensiled cellulosic material.

A probiotic egg wash for the exterior surface of the eggshell that is ingested by the developing embryo resulting in an established GI tract microbiome that promotes health and outcompetes potential pathogens such as Salmonella is provided herein. In the preferred embodiment, the probiotic wash is composed at least of L. casei, L. rhamnosus, L. planitarum, L. paracasei, and/or B. lactis at a concentration of between 10.sup.2 to 10.sup.9 CFU per egg.

A probiotic egg wash for the exterior surface of the eggshell that is ingested by the developing embryo resulting in an established GI tract microbiome that promotes health and outcompetes potential pathogens such as Salmonella is provided herein. In the preferred embodiment, the probiotic wash is composed at least of L. casei, L. rhamnosus, L. planitarum, L. paracasei, and/or B. lactis at a concentration of between 10.sup.2 to 10.sup.9 CFU per egg.

Provided is a novel Lactobacillus Plantarum strain and a composition for preventing or treating a metabolic disease including the same. A Lactobacillus Plantarum (Accession No. KCTC 14107BP) according to the present invention may inhibit fat accumulation in white adipose tissue, brown adipose tissue, and liver tissue. The Lactobacillus Plantarum strain may exhibit excellent blood glucose improvement effect, and in particular, may reduce a fasting blood glucose level. The Lactobacillus Plantarum strain may effectively ameliorate insulin resistance by improving glucose tolerance and increasing insulin sensitivity. In addition, the Lactobacillus Plantarum strain may regulate a concentration of metabolic hormones in blood. Therefore, the Lactobacillus Plantarum strain may be usefully used to prevent or treat a metabolic disease.